Results
1 -
10 of
23Targeting FGFR for the Treatment of Breast Cancer, Resistance to Targeted Therapies in Breast Cancer FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism, Calcified Tissue International Epithelialu2013mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells, Gastric Cancer FGFR-Inhibition beim cholangiozellul??ren Karzinom, Der Onkologe Targeting FGFR in Squamous Cell Carcinoma of the Lung, Targeted Oncology Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma, Targeted Oncology Rationale for targeting fibroblast growth factor receptor signaling in breast cancer, Breast Cancer Research and Treatment Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition, Oncogene The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase, Oncogene